Table 1.
Effect of resveratrol on the body mass, lens mass, blood glucose concentration and blood fructosamine concentration in diabetic rats.
| Parameter/Group | C | D | D+R10 | D+R20 |
|---|---|---|---|---|
| Initial body mass (g) | 281.2 ± 3.8 | 283.2 ± 6.2 | 282.0 ± 3.7 | 276.6 ± 5.5 |
| Start body mass (g) | 312.8 ± 5.9 | 250.2 ± 8.7 *** | 239.4 ± 4.9 *** | 242.8 ± 6.6 *** |
| Final body mass (g) | 344.9 ± 5.5 | 228.2 ± 10.9 *** | 212.2 ± 5.7 *** | 228.1 ± 7.4 *** |
| Body mass gain (g) | 32.1 ± 2.8 | −22.0 ± 5.1 *** | −27.2 ± 4.9 *** | −14.7 ± 3.5 *** |
| Lens mass (mg) | 47.2 ± 0.5 | 42.9 ± 1.7 *** | 42.8 ± 0.4 *** | 43.7 ± 0.5 *** |
| Glucose in the blood (mg/dL) | 141.4 ± 11.0 | 641.9 ± 28.6 *** | 613.9 ± 55.5 *** | 641.7 ± 51.6 *** |
| Fructosamine in the blood (µmol/L albumin) | 275.1 ± 8.1 | 498.4 ± 21.3 *** | 489.7 ± 19.4 *** | 471.5 ± 54.7 ** |
C—control, non-diabetic rats; D—diabetic rats; D+R10—diabetic rats receiving resveratrol (10 mg/kg po for 4 weeks); D+R20—diabetic rats receiving resveratrol (20 mg/kg po for 4 weeks). Results are presented as means ± SEM (n = 8–9). ** p < 0.01, *** p < 0.001—statistically significantly different from the C group.